» Articles » PMID: 10980141

Astrocytes Give Rise to Oligodendrogliomas and Astrocytomas After Gene Transfer of Polyoma Virus Middle T Antigen in Vivo

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2000 Sep 12
PMID 10980141
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

The cells of origin for oligodendrogliomas and astrocytomas are not known but are presumed to be oligodendrocyte and astrocyte precursors, respectively. In this paper we report the generation of mixed gliomas from in vivo transformation of glial fibrillary acidic protein (GFAP)-positive cells (differentiated astrocytes) with polyoma virus middle T antigen (MTA). MTA is a powerful oncogene that activates a number of signal transduction pathways, including those proposed to be involved in gliomagenesis, and has been shown to induce tumors in many cell types. We have achieved transfer of MTA expression specifically to GFAP(+) cells in vivo using somatic cell gene transfer, and find resultant formation of anaplastic gliomas with mixed astrocytoma and oligodendroglioma morphological features. We conclude that GFAP- expressing astrocytes, with appropriate signaling abnormalities, can serve as the cell of origin for oligodendrogliomas, astrocytomas, or mixed gliomas.

Citing Articles

Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspective.

Mathur R, Wang Q, Schupp P, Nikolic A, Hilz S, Hong C Cell. 2024; 187(2):446-463.e16.

PMID: 38242087 PMC: 10832360. DOI: 10.1016/j.cell.2023.12.013.


Advances in Immunocompetent Mouse and Rat Models.

Bu W, Li Y Cold Spring Harb Perspect Med. 2023; 14(3.

PMID: 37217281 PMC: 10810718. DOI: 10.1101/cshperspect.a041328.


IGFBP2: integrative hub of developmental and oncogenic signaling network.

Li T, Forbes M, Fuller G, Li J, Yang X, Zhang W Oncogene. 2020; 39(11):2243-2257.

PMID: 31925333 PMC: 7347283. DOI: 10.1038/s41388-020-1154-2.


Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes.

Bu W, Liu Z, Jiang W, Nagi C, Huang S, Edwards D Cancer Res. 2018; 79(1):61-71.

PMID: 30401712 PMC: 6318055. DOI: 10.1158/0008-5472.CAN-18-1087.


Targeting Oncogenes into a Defined Subset of Mammary Cells Demonstrates That the Initiating Oncogenic Mutation Defines the Resulting Tumor Phenotype.

Holloway K, Sinha V, Bu W, Toneff M, Dong J, Peng Y Int J Biol Sci. 2016; 12(4):381-8.

PMID: 27019623 PMC: 4807158. DOI: 10.7150/ijbs.12947.


References
1.
Bautch V, Toda S, Hassell J, Hanahan D . Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogene. Cell. 1987; 51(4):529-37. DOI: 10.1016/0092-8674(87)90122-x. View

2.
Holland E, Celestino J, Dai C, Schaefer L, Sawaya R, Fuller G . Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nat Genet. 2000; 25(1):55-7. DOI: 10.1038/75596. View

3.
Wiestler O, Aguzzi A, Williams R, Wagner E, Boulter C, Kleihues P . Tumour induction in fetal brain transplants exposed to the viral oncogenes polyoma middle T and v-src. IARC Sci Publ. 1989; (96):267-74. View

4.
Rassoulzadegan M, Courtneidge S, LOUBIERE R, el Baze P, Cuzin F . A variety of tumours induced by the middle T antigen of polyoma virus in a transgenic mouse family. Oncogene. 1990; 5(10):1507-10. View

5.
Aguzzi A, Wagner E, Williams R, Courtneidge S . Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. New Biol. 1990; 2(6):533-43. View